PH21283A - The use of bendazac and its salts in the treatment of retinitis pigmentosa - Google Patents

The use of bendazac and its salts in the treatment of retinitis pigmentosa

Info

Publication number
PH21283A
PH21283A PH30561A PH30561A PH21283A PH 21283 A PH21283 A PH 21283A PH 30561 A PH30561 A PH 30561A PH 30561 A PH30561 A PH 30561A PH 21283 A PH21283 A PH 21283A
Authority
PH
Philippines
Prior art keywords
bendazac
salts
treatment
retinitis pigmentosa
pigmentosa
Prior art date
Application number
PH30561A
Other languages
English (en)
Inventor
Silvestrini Bruno
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of PH21283A publication Critical patent/PH21283A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH30561A 1983-04-18 1984-04-16 The use of bendazac and its salts in the treatment of retinitis pigmentosa PH21283A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20649/83A IT1194564B (it) 1983-04-18 1983-04-18 Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa

Publications (1)

Publication Number Publication Date
PH21283A true PH21283A (en) 1987-09-28

Family

ID=11170034

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30561A PH21283A (en) 1983-04-18 1984-04-16 The use of bendazac and its salts in the treatment of retinitis pigmentosa

Country Status (7)

Country Link
US (1) US4554288A (it)
EP (1) EP0131317B1 (it)
JP (1) JPS6034912A (it)
AU (1) AU568847B2 (it)
DE (1) DE3414569A1 (it)
IT (1) IT1194564B (it)
PH (1) PH21283A (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230441B (it) 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
US7354574B2 (en) * 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CA3144861A1 (en) 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN116850183A (zh) * 2021-04-30 2023-10-10 远大医药（中国）有限公司 用于治疗近视的方法和药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US27253A (en) * 1860-02-21 Engraver s vise
IL28032A (en) 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3625970A (en) * 1968-04-17 1971-12-07 Cutter Lab 1-(disubstituted phenyl or benzyl)-1h-indazol-3-yloxyacetic acid
IT1050741B (it) * 1975-12-01 1981-03-20 Acraf Utilizzazione degli acidi i benzil ih indazol 3 carbossilici sostituiti e loro derivati nel campo della contraccezione femminile
IT1131779B (it) * 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) * 1981-11-27 1988-01-28 Acraf Trattamento della cataratta

Also Published As

Publication number Publication date
JPH0410445B2 (it) 1992-02-25
EP0131317A3 (en) 1987-01-07
AU568847B2 (en) 1988-01-14
IT8320649A0 (it) 1983-04-18
US4554288A (en) 1985-11-19
EP0131317B1 (en) 1989-12-27
DE3414569A1 (de) 1984-11-15
AU2704284A (en) 1984-10-25
IT1194564B (it) 1988-09-22
EP0131317A2 (en) 1985-01-16
JPS6034912A (ja) 1985-02-22

Similar Documents

Publication Publication Date Title
GB2159413B (en) Mixture of salts and uses of the mixture
DE3480538D1 (en) Electrostatic water treatment and electrode therefor
EP0234938A3 (en) Application of tetrathiafulvalenes in bioelectrochemical processes
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
PH19156A (en) Dihydrocyclosporin d in the treatment of multiple sclerosis
GB8309573D0 (en) Water treatment composition
GB2135882B (en) Material for use in the treatment of spontaneous abortions
PH21283A (en) The use of bendazac and its salts in the treatment of retinitis pigmentosa
DE3460337D1 (en) Installation for the heat treatment of minerals in pulverulent form
GB8321253D0 (en) Surface treatment of metal
DE3471652D1 (en) Diurethane-diureas and use
GB8430209D0 (en) Surface treatment of articles of titanium
DE3264378D1 (en) Medicaments for the treatment of obesity and hyperlipoidemia
DE3474109D1 (en) Compounds and compositions for use in preventing and treating obesity
GB2147008B (en) Surface treatment
PH24676A (en) Use of mini-somatostatin in the treatment of senile dementia
GB8503691D0 (en) Formation treatment
GB2131420B (en) Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
GB8406136D0 (en) Treatment of surface rotatable workpiece
DE3463048D1 (en) Furan-3-hydroxamates and their use
GB2114435B (en) Heating baths and/or bathrooms
DE3365608D1 (en) Coating composition and the use thereof
DE3373477D1 (en) Amino-substituted dibenzodioxaphosphepines and dioxaphosphocines
DE3275648D1 (en) Pseudotropyl halogeno-benzoates and their use in migraine treatment
GB2131419B (en) Pseudotropyl halogeno-benzoates and their use in migraine treatment